Ali Namvaran (D.V.M, Ph.D.)

University of Nebraska Medical Center (UNMC)

United States

Post-Doc Research Associate, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center  

Research and Setting Up Some New Research Projects

Medical and Marketing Manager, Zahravi Pharmaceutical Co.

• Managing and training medical representatives all around the country.
• Cooperating with Roche Hoffmann Co. In partnership production.
• R&D cooperating in the new agent and medicines development (anticancer, transplant, and Multiple sclerosis medicines).

1. Neuroscience and cancer pharmacology, particularly innovative strategies for treating colorectal cancer using rodent models, cell lines, and plant-based bioactives.
2. Pain modulation and chemotherapy-induced neuropathy, with a focus on the antinociceptive effects of herbal agents against drugs like Cisplatin, Vincristine, and Methotrexate.
3. Neurodegenerative disorders, including histopathological studies of Alzheimer’s disease and experimental models of seizures.
4. Diabetes and metabolic disease models, including induction of neuropathic pain and evaluation of hepatotoxicity.
5. Advanced pharmacognosy and drug delivery, with expertise in extraction of plant compounds, antibiotic resistance testing, and in vivo/in vitro pharmacological screening.
6. Cardiovascular complications in HIV-infected individuals, particularly:
7. Mechanisms of sudden cardiac death, mitochondrial dysfunction, and oxidative stress under antiretroviral therapy.
8. Assessment of methylglyoxal as a novel cardiotoxic biomarker in HIV models.
9. Non-invasive measurement tools for estimating blood pressure using ECG and Doppler ultrasound in humanized mouse models.
10. Cardiac fibrosis, arrhythmias, and multi-organ involvement in chronic HIV infection.